| Short Description : | Recombinant-Human FLT3 Ligand-protein was developed from cho cells. For use in research applications. |
| Host: | CHO Cells |
| Note: | STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Dilution Range: | Spin the vial and reconstite in distilled water to a concentration not less than 0.1 mg/mL. This can then be diluted into other buffers. |
| Formulation: | Lyophilised from 0.2 Mu m filtered PBS solution pH7.0. |
| Storage Instruction: | Can be stored in working aliquots at°C-°C C for one month, or at-20°C C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. NA |
| Endotoxin: | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg (1EU/µg). NA |
| Immunoreactivity: | The ED (50) was determined by the dose-dependent stimulation of the proliferation of Human AML5 cells was found to be in the range of.0 ng/ml. NA |
| Gene Symbol: | FLT3LG |
| Gene ID: | 2323 |
| Uniprot ID: | FLT3L_HUMAN |
| Immunogen: | Optimized DNA sequence encoding Human FLT-3 Ligandmature chain was expressed in CHO cells NA |
| Immunogen Region: | Mature chain |
| Immunogen Sequence: | MTVLAPAWSP TTYLLLLLLL SSGLSGTQDC SFQHSPISSD FAVKIRELSD YLLQDYPVTV ASNLQDEELC GGLWRLVLAQ RWMERLKTVA GSKMQGLLER VNTEIHFVTK CAFQPPPSCL RFVQTNISRL LQETSEQLVA LKPWITRQNF SRCLELQCQP DSSTLPPPWS PRPLEATAPT A PQPPLLLLL LLPVGLLLLA AAWCLHWQRT RRRTPRPGEQ VPPVPSP |
Information sourced from Uniprot.org
